CAXTON ASSOCIATES LLP

Position in HAE — Haemonetics Corp

CIK 2051323 LONDON, X0

Position in HAE

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$256,950

+$41,071 QoQ

Shares Held

3,426

+0.9% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#221

of 329 holders

Holding Since

Mar 2025

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CAXTON ASSOCIATES LLP holds $62,784,476 across 6 Medical Devices names. HAE ranks #5 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PEN	Penumbra Inc	179,384	$56,640,498
2	BIO	Bio-Rad Laboratories, Inc.	13,875	$4,073,838
3	NEOG	Neogen Corp	149,164	$1,340,984
4			16,855	$419,352
5	HAE	Haemonetics Corp This page	3,426	$256,950
6	CTKB	Cytek Biosciences, Inc.	11,931	$52,854

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$256,950	3,426	+0.9%	Shares	Sole	2026-08-14
2025-03-31	$215,879	3,397	—	Shares	Sole	2025-05-16
No filing history on record for this holder in this stock.